The Low DoseThe GLP-1 price desk
Programme

WeightWatchers Clinic tirzepatide review

Advertised at $25, billed at $74. Position 0 of 18 on our board.

Updated 2026-09-18

DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.

Advertised at $25 a month. Bills $74 a month after two months, on a twelve-month contract, and buys no medication whatsoever.

That is the widest expectation gap on the board. The GLP-1 prescription is billed separately, which is why real totals are commonly reported between $199 and $449 a month.

The numbers

WeightWatchers Clinic · tirzepatide
Advertised$25/mo
Membership$74/mo
Billed$74/mo
Advertised-to-billed gap+$49/mo
Per year$888
Board position0 of 18, cheapest first

Membership only. Medication is billed separately, which is what takes real-world totals to $199-$449+.

Where the gap is

Threefold: a $25 rate that lasts two months, a $74 rate that runs for ten more, and a medication cost that is not in either. The twelve-month commitment is the part to weigh hardest.

Against the board

Membership alone is about $888 a year. Add branded medication and an uninsured patient is well past $4,000 — against a $1,500 board floor that includes the drug.

ProgrammeAdvertisedBilledGapVs board floor
Coreage Rx$149$199+$50+$74/mo
Trimi$125$125none
Ozari Health$125$125none
Fifty 410$133$133none+$8/mo
PlexusDx$129$189+$60+$64/mo
Ivím Health$199$199none+$74/mo
Zealthy$216$216none+$91/mo
Hims & Hers$199$238+$39+$113/mo

How the programme works

The WeightWatchers medical arm (Med+), pairing the long-established behaviour programme with GLP-1 prescribing and insurance support. Membership is separate from medication.

Verified facts

  • Med+ membership advertised at $25/month for the first two months on a 12-month plan.
  • Membership then continues at $74/month on the 12-month plan or $84/month on the 6-month plan.
  • The cost of GLP-1 medication is not included in the membership.
  • All-in monthly cost commonly reported between $199 and $449 or more depending on medication and coverage.
  • Offers an insurance cost estimator and savings-card support for branded medication.

Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.

For it

  • The behaviour-change programme behind it is the most established in the category.
  • Works with FDA-approved branded medication and helps pursue insurance coverage.
  • Insurance cost estimator is genuinely useful before you commit.

Against it

  • The $25 rate lasts two months and applies only on a 12-month commitment.
  • Medication is an entirely separate cost from the membership.
  • The 12-month plan is a long commitment for a treatment many people stop within eight weeks.

Read this bit. The $25/month headline is two months on a twelve-month contract, and it buys no medication at all.

Score

3.2 out of 5 on our rubric, which is fixed before assessment and published on how we rate.

CriterionWeightScore
True monthly cost30%2.8 / 5
Price honesty20%2.9 / 5
Clinical support20%3.9 / 5
Pharmacy sourcing15%4 / 5
Cancelling15%2.8 / 5

Verdict

Best behaviour programme in the category attached to the most misread price on this board. Insured, it can win. Uninsured, it cannot.

More from the desk

  • Coreage Rx tirzepatide review

    Advertised at $149, billed at $199. Position 1 of 18 on our board.

  • Trimi tirzepatide review

    Advertised at $125 and billed at $125 — no gap. Position 2 of 18 on our board.

  • Ozari Health tirzepatide review

    Advertised at $125 and billed at $125 — no gap. Position 3 of 18 on our board.

  • Cheapest right now

    Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.

  • Six fee traps

    Every advertised-to-billed gap on our board comes from one of these six structures. Learn them and you can read any of these sites in ninety seconds.

  • Where the traps are

    The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.